Evidence map›Paper›PMID 35432714›Full record

ArticleThe World Allergy Organization journal2022

Shrimp sensitization in house dust mite algerian allergic patients: A single center experience.

Lydia Lamara Mahammed, Brahim Belaid, Lylia Meriem Berkani, Fatma Merah, Sarah Yasmine Rahali, Anis Ait Kaci, Ismahane Berkane, Wafa Sayah, Ines Allam, Reda Djidjik

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The World Allergy Organization journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Lydia Lamara MahammedImmunology Department, Beni-Messous Teaching Hospital, Faculty of Pharmacy, University of Algiers, Algiers, Algeria.
Brahim BelaidImmunology Department, Beni-Messous Teaching Hospital, Faculty of Pharmacy, University of Algiers, Algiers, Algeria.
Lylia Meriem BerkaniImmunology Department, Beni-Messous Teaching Hospital, Faculty of Pharmacy, University of Algiers, Algiers, Algeria.
Fatma MerahImmunology Department, Beni-Messous Teaching Hospital, Faculty of Pharmacy, University of Algiers, Algiers, Algeria.
Sarah Yasmine RahaliImmunology Department, Beni-Messous Teaching Hospital, Faculty of Pharmacy, University of Algiers, Algiers, Algeria.
Anis Ait KaciImmunology Department, Beni-Messous Teaching Hospital, Faculty of Pharmacy, University of Algiers, Algiers, Algeria.
Ismahane BerkaneImmunology Department, Beni-Messous Teaching Hospital, Faculty of Pharmacy, University of Algiers, Algiers, Algeria.
Wafa SayahImmunology Department, Beni-Messous Teaching Hospital, Faculty of Pharmacy, University of Algiers, Algiers, Algeria.
Ines AllamImmunology Department, Beni-Messous Teaching Hospital, Faculty of Pharmacy, University of Algiers, Algiers, Algeria.
Reda DjidjikImmunology Department, Beni-Messous Teaching Hospital, Faculty of Pharmacy, University of Algiers, Algiers, Algeria.
University of Algiers Benyoucef Benkhedda · DZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cross-reactivity between shrimp and house dust mite (HDM) proteins has been widely documented. However, a significant geographical variability in sensitization patterns and cross-reactive allergens has been reported which may impact the diagnosis and management of shrimp allergy among HDM-shrimp co-sensitized patients. This study aimed to investigate the prevalence of shrimp and tropomyosin sensitization among HDM-allergic patients in order to understand the local epidemiology to inform the development of targeted diagnostic and therapeutic tools. Methods: Four hundred forty-six (446) HDM-allergic patients and 126 atopic controls were screened for shrimp-specific IgE using the IMMULITE 2000 XPI® System. HDM-shrimp sensitized subjected were also tested for IgE tropomyosin (nPen m 1) and thoroughly interviewed about their shellfish consumption habits. Tropomyosin sensitized patients were subjected to further analysis including measurement of IgE specific to squid and crab. Results: The prevalence of shrimp sensitization in the HDM-allergic population was 20.4% Conclusions: Shrimp allergy seems to be strictly dependent on HDM sensitization, at least in this geographical area. Therefore, HDM allergic patients should be systematically screened for shrimp sensitization and asked about the consumption of shellfish. Tropomyosin is a major and clinically relevant shrimp allergen that accounts for shellfish-HDM cross-reactivity. However, other components could be involved.

Indexed as

AK, arginine kinaseAllergyCLEIA, chemiluminescent enzyme immunoassayCRD, component resolved diagnosticCross-reactivityDBPCFC, double-blind placebo-controlled food challengeHouse dust mitesMLC, myosin light chainOFC, oral food challengeSCBP, sarcoplasmic calcium-binding proteinShrimpSPT, skin prick testTM, tropomyosinTropomyosin

Identifiers

PMID35432714
PMCPMC8988002
OpenAlexW4224238099

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.